Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide

  1. Antelo, M.L.
  2. De Las Heras, N.
  3. Porras, J.R.G.
  4. Kerguelen, A.
  5. Raya, J.M.
Aldizkaria:
Expert Review of Hematology

ISSN: 1747-4094,  1747-4086

Argitalpen urtea: 2015

Alea: 8

Zenbakia: 6

Orrialdeak: 819-835

Mota: Berrikuspena

DOI: 10.1586/17474086.2015.1088779 GOOGLE SCHOLAR
Datuen iturria: Scopus